| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |